1818 160. Bemis JE, Vu CB, Xie R, et al. Discovery of oxazolo[4, 5-b] pyridines and related heterocyclic analogs as novel SIRT1 activators. Bioorg Med Chem Lett. 2009;19:2350–3. 161. Feige JN. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by en- hancing fat oxidation. Cell Metab. 2008;8:347–58. 162. Sitris Pharmaceuticals. Sirtris development pipeline. Accessed August 15th 2010. http://www.sirtrispharma.com/pipeline.html. 163. Pacholec M, Bleasdale JE, Chrunyk B, et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem. 2010;285:8340–51. 164. van Boekel G, Loves S, van Sorge A, Ruinemans-Koerts J, Rijnders T, de Boer H. Weight loss in obese men by caloric restriction and high-dose diazoxide-mediated insulin suppression. Diab Obes Metab. 2008;10:1195–203. 165. Due A, Flint A, Eriksen G, et al. No effect of inhibition of insulin secretion by diazoxide on weight loss in hyperinsulinaemic obese subjects during an 8-week weight-loss diet. Diab Obes Metab. 2007;9:566–74. 166. Rupnick MA, Panigrahy D, Zhang CY, et al. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA. 2002;99:10730–5. Witkamp 167. Cao Y. Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat Rev Drug Discov. 2010;9:107–15. 168. Reitman ML. Magic bullets melt fat. Nat Med. 2004;10:581–2. 169. Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W. Reversal of obesity by targeted ablation of adipose tissue. Nat Med. 2004;10:625–32. 170. Cao Y. Angiogenesis modulates adipogenesis and obesity. J Clin Invest. 2007;117:2362–8. 171. Tiwari A, Maiti P. TGR5: an emerging bile acid G-protein- coupled receptor target for the potential treatment of metabolic disorders. Drug Discov Today. 2009;14:523–30. 172. Watanabe M. Bile acids induce energy expenditure by promot- ing intracellular thyroid hormone activation. Nature. 2006;439:484–9. 173. Thomas C, Gioiello A, Noriega L, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 2009;10:167–77. 174. Pellicciari R, Gioiello A, Macchiarulo A, et al. Discovery of 6α- ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity. J Med Chem. 2009;52:7958–61.